Literature DB >> 18497415

How to interpret figures in reports of clinical trials.

Stuart J Pocock1, Thomas G Travison, Lisa M Wruck.   

Abstract

Mesh：

Year:  2008        PMID： 18497415      PMCID： PMC2394578          DOI： 10.1136/bmj.39561.548924.94

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  19 in total

Review 1.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

Authors:  D Moher; K F Schulz; D G Altman
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

2.  Achieving graphical excellence: suggestions and methods for creating high-quality visual displays of experimental data.

Authors:  D L Schriger; R J Cooper
Journal:  Ann Emerg Med       Date:  2001-01       Impact factor: 5.721

3.  Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research Trial (SPORT): a randomized trial.

Authors:  James N Weinstein; Tor D Tosteson; Jon D Lurie; Anna N A Tosteson; Brett Hanscom; Jonathan S Skinner; William A Abdu; Alan S Hilibrand; Scott D Boden; Richard A Deyo
Journal:  JAMA       Date:  2006-11-22       Impact factor: 56.272

4.  From submission to publication: a retrospective review of the tables and figures in a cohort of randomized controlled trials submitted to the British Medical Journal.

Authors:  David L Schriger; Reshmi Sinha; Sara Schroter; Pamela Y Liu; Douglas G Altman
Journal:  Ann Emerg Med       Date:  2006-09-15       Impact factor: 5.721

5.  2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

Authors:  Ian Smith; Marion Procter; Richard D Gelber; Sébastien Guillaume; Andrea Feyereislova; Mitch Dowsett; Aron Goldhirsch; Michael Untch; Gabriella Mariani; Jose Baselga; Manfred Kaufmann; David Cameron; Richard Bell; Jonas Bergh; Robert Coleman; Andrew Wardley; Nadia Harbeck; Roberto I Lopez; Peter Mallmann; Karen Gelmon; Nicholas Wilcken; Erik Wist; Pedro Sánchez Rovira; Martine J Piccart-Gebhart
Journal:  Lancet       Date:  2007-01-06       Impact factor: 79.321

6.  Uterine-artery embolization versus surgery for symptomatic uterine fibroids.

Authors:  Richard D Edwards; Jonathan G Moss; Mary Ann Lumsden; Olivia Wu; Lilian S Murray; Sara Twaddle; Gordon D Murray
Journal:  N Engl J Med       Date:  2007-01-25       Impact factor: 91.245

7.  Medicine residents' understanding of the biostatistics and results in the medical literature.

Authors:  Donna M Windish; Stephen J Huot; Michael L Green
Journal:  JAMA       Date:  2007-09-05       Impact factor: 56.272

8.  Subgroup analysis and other (mis)uses of baseline data in clinical trials.

Authors:  S F Assmann; S J Pocock; L E Enos; L E Kasten
Journal:  Lancet       Date:  2000-03-25       Impact factor: 79.321

9.  Coronary intervention for persistent occlusion after myocardial infarction.

Authors:  Judith S Hochman; Gervasio A Lamas; Christopher E Buller; Vladimir Dzavik; Harmony R Reynolds; Staci J Abramsky; Sandra Forman; Witold Ruzyllo; Aldo P Maggioni; Harvey White; Zygmunt Sadowski; Antonio C Carvalho; Jamie M Rankin; Jean P Renkin; P Gabriel Steg; Alice M Mascette; George Sopko; Matthias E Pfisterer; Jonathan Leor; Viliam Fridrich; Daniel B Mark; Genell L Knatterud
Journal:  N Engl J Med       Date:  2006-11-14       Impact factor: 91.245

10.  Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial.

Authors:  Theodore Mazzone; Peter M Meyer; Steven B Feinstein; Michael H Davidson; George T Kondos; Ralph B D'Agostino; Alfonso Perez; Jean-Claude Provost; Steven M Haffner
Journal:  JAMA       Date:  2006-11-13       Impact factor: 56.272
View more
  8 in total

1.  Physician Interpretation of Data of Uncertain Clinical Utility in Oncology Prescription Drug Promotion.

Authors:  Vanessa Boudewyns; Amie C O'Donoghue; Ryan S Paquin; Kathryn J Aikin; Kate Ferriola-Bruckenstein; Victoria M Scott
Journal:  Oncologist       Date:  2021-09-28

Review 2.  Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis-a meta-analysis of comparative and non-comparative clinical trials.

Authors:  Julien Zwang; Piero L Olliaro
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

Review 3.  Efficacy and safety of praziquantel 40 mg/kg in preschool-aged and school-aged children: a meta-analysis.

Authors:  Julien Zwang; Piero Olliaro
Journal:  Parasit Vectors       Date:  2017-01-26       Impact factor: 3.876

4.  Self-perceived competencies on evidence-based medicine in medical students and physicians registered in a virtual course: a cross-sectional study.

Authors:  Milton A Romero-Robles; David R Soriano-Moreno; Fabrizio M García-Gutiérrez; I Benjamín Condori-Meza; Caroline C Sing-Sánchez; Sandy P Bulnes Alvarez; Christoper A Alarcon-Ruiz; Alvaro Taype-Rondan; Andres Viteri-García
Journal:  Med Educ Online       Date:  2022-12

Review 5.  Statistical methods and graphical displays of quality of life with survival outcomes in oncology clinical trials for supporting the estimand framework.

Authors:  Kentaro Sakamaki; Takuya Kawahara
Journal:  BMC Med Res Methodol       Date:  2022-10-04       Impact factor: 4.612

6.  Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis.

Authors:  Julien Zwang; Elizabeth A Ashley; Corine Karema; Umberto D'Alessandro; Frank Smithuis; Grant Dorsey; Bart Janssens; Mayfong Mayxay; Paul Newton; Pratap Singhasivanon; Kasia Stepniewska; Nicholas J White; François Nosten
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

7.  Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis.

Authors:  Julien Zwang; Piero Olliaro; Hubert Barennes; Maryline Bonnet; Philippe Brasseur; Hasifa Bukirwa; Sandra Cohuet; Umberto D'Alessandro; Abdulaye Djimdé; Corine Karema; Jean-Paul Guthmann; Sally Hamour; Jean-Louis Ndiaye; Andreas Mårtensson; Claude Rwagacondo; Issaka Sagara; Albert Same-Ekobo; Sodiomon B Sirima; Ingrid van den Broek; Adoke Yeka; Walter R J Taylor; Grant Dorsey; Milijaona Randrianarivelojosia
Journal:  Malar J       Date:  2009-08-23       Impact factor: 2.979

8.  Clinical tolerability of artesunate-amodiaquine versus comparator treatments for uncomplicated falciparum malaria: an individual-patient analysis of eight randomized controlled trials in sub-Saharan Africa.

Authors:  Julien Zwang; Grant Dorsey; Abdoulaye Djimdé; Corine Karema; Andreas Mårtensson; Jean-Louis Ndiaye; Sodiomon B Sirima; Piero Olliaro
Journal:  Malar J       Date:  2012-08-02       Impact factor: 2.979
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.